Parkinson's disease is the second most common neurodegenerative disease. Over the last 30 years, studies have shown that a ...
A spatial multi-omics study in Nature Communications identifies disease-associated oligodendrocytes whose interleukin 33–ST2 ...
Researchers have developed a chronic intranasal rotenone mouse model that reproduces the brain-first, olfactory-to-midbrain ...
Researchers at the University of Oxford have uncovered a previously unrecognized protective role for microglia, the brain's ...
Researchers have identified a previously unrecognized protective role for the brain’s immune cells in people with Parkinson’s disease.
The Parkinson’s enzyme therapy is still heading toward the clinic, and the deal could grow by up to $1.17bn in milestone ...
The protein alpha-synuclein is abundant in healthy brains and plays an important role in enabling communication between nerve ...
Parkinson’s disease is now the fastest-growing neurodegenerative disease in the world. In the U.S. alone, over 1 million people are living with it. By 2040, it is believed that more than 17 million ...
Agenda to feature progress for AL137, its lead anti-amyloid beta antibody; AL164, its tau siRNA program; and AL062, its alpha-synuclein siRNA ...
Alzheimer’s disease is the most common cause of dementia. It gradually damages brain cells, leading to memory loss, problems ...
Alan Alda’s first symptoms of Parkinson’s disease weren’t the typical tremors, stiffness or slow movement. It was throwing a pillow at his wife in his sleep. “I had a symptom, which at the time was ...
Researchers at the University of Oxford have uncovered a previously unrecognized protective role for microglia, the brain's resident immune cells, in Parkinson's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results